| Literature DB >> 28919790 |
Abstract
One of the main fundamental mechanisms of antibiotic resistance in Gram-negative bacteria comprises an effective change in the membrane permeability to antibiotics. The Gram-negative bacterial complex cell envelope comprises an outer membrane that delimits the periplasm from the exterior environment. The outer membrane contains numerous protein channels, termed as porins or nanopores, which are mainly involved in the influx of hydrophilic compounds, including antibiotics. Bacterial adaptation to reduce influx through these outer membrane proteins (Omps) is one of the crucial mechanisms behind antibiotic resistance. Thus to interpret the molecular basis of the outer membrane permeability is the current challenge. This review attempts to develop a state of knowledge pertinent to Omps and their effective role in antibiotic influx. Further, it aims to study the bacterial response to antibiotic membrane permeability and hopefully provoke a discussion toward understanding and further exploration of prospects to improve our knowledge on physicochemical parameters that direct the translocation of antibiotics through the bacterial membrane protein channels.Entities:
Keywords: Gram-negative bacteria; antibiotic resistance; antibiotics; cell envelope; influx; nanopores; protein channels
Year: 2017 PMID: 28919790 PMCID: PMC5587131 DOI: 10.2147/IDR.S144299
Source DB: PubMed Journal: Infect Drug Resist ISSN: 1178-6973 Impact factor: 4.003
Figure 1(A) Antibiotic resistance (an overview). (B) Various mechanisms of antibiotic resistance employed by Gram-negative bacteria (an overview). (C) Structural representation of outer membrane vesicles.
Abbreviation: Omps, outer membrane proteins.
Figure 2Antibiotic resistance mechanism associated with Omps modification. Antibiotic β-lactam molecules are represented by green stars, and Omps as trimers by gray cylinder. The width of the straight arrows imitating the level of β-lactam penetration via Omps. The curved arrows exemplify the uptake failure/reduce uptake occurring with the following: B: decrease in the level of wild-type Omps expression; C: expression of restricted-channel Omps; D: mutation or modification of the functional properties of a porin channel; and E: synthesis of modified Omps with significant constriction.
Abbreviation: Omps, outer membrane proteins.
Crucial Omps studied in different Gram-negative bacterial species
| Species | Investigative porins or Omps |
|---|---|
| OmpC, | |
| Omp36, | |
| OmpE36, | |
| OmpK36, | |
| OccD1 (OprD), OccD2 (OpdC), OccD3 (OpdP), OccD4 (OpdT), OccD5 (OpdI), OccD6 (OprQ), OccD7 (OpdB), OccD8 (OpdJ) | |
| OccAB1–OccAB5, |
Notes: Studies by Nikaido,5,6 Pages et al,22,42 and Schulz28 provide further insight.
Abbreviation: Omps, outer membrane proteins.
Conclusive investigations with different Omps studied in different Gram-negative bacterial species
| Conclusive investigation | Omps | Species |
|---|---|---|
| Measured the flux of charged β-lactamase inhibitors sulbactam, tazobactam, and avibactam using ETP zero-current assay and MS | OmpF | |
| Measured the transport of charged β-lactamase inhibitors sulbactam, tazobactam, and avibactam using ETP zero-current assay | OmpC | |
| Measured the permeability of carbapenems via different mutant proteins from different clinical isolates using ETP and LSA | OmpC | |
| Quantified norfloxacin uptake using semiquantitative optofluidic assay | OmpF | |
| Quantified and explained the mechanism of small antibiotic molecule enrofloxacin uptake using ETP and MS | OmpF | |
| Quantified and demonstrated the translocation of imipenem, ceftazidime, and cefepime using ETP | OmpF | |
| Demonstrated the interaction and binding of antibiotic meropenem with channel using ETP | OmpF | |
| Demonstrated the translocation of polypeptides using ETP | OmpF | |
| Demonstrated the permeation of enrofloxacin across the OmpF channel and modulation of the affinity site in the presence of magnesium using ETP and MS | OmpF | |
| Demonstrated the transport of ampicillin and benzylpenicillin using ETP, MS, MIC, and LSA | OmpF | |
| Demonstrated the role of charged residues in channel constriction, channel conductance, ion selectivity, and voltage gating using ETP and MS | OmpF | |
| Demonstrated important electrostatic interactions between ions and charge distribution within the channel that govern ion permeation and selectivity using MS | OmpF | |
| Demonstrated the ionization states of titratable amino acid residues and calculated self-consistently the electric potential distribution within channel using MS | OmpF | |
| Demonstrated the movement of single ampicillin molecule via channel using ETP and MS | OmpF | |
| Demonstrated the molecular origin of cation selectivity within Omps by defining the effect of alkali metal ions atomic radii on the binding-site affinity using ETP and MS | OmpF | |
| Demonstrated the specific interaction of grepafloxacin, ciprofloxacin, moxifloxacin, and nalidixic acid with pore using UV–visible spectroscopic measurements | OmpF | |
| Demonstrated the permeation of moxifloxacin across membrane channel and protein–antibiotic interaction using ETP, MS and FRET | OmpF | |
| Investigated the effects of four polyamines (putrescine, cadaverine, spermidine, and spermine) on the activity of bacterial porins using ETP patch clamp | OmpF | |
| Demonstrated the channel functional characteristics of four single amino acid substitutions and effect of deletion mutant in constriction loop L3 using ETP | OmpF | |
| Demonstrated the role of the constriction loop in voltage gating using ETP and crystallographic analysis | OmpF | |
| Employed fluorescence quenching as a tool to investigate the antibiotic interactions with bacterial protein, using nalidixic acid and moxifloxacin, within the pore | OmpF | |
| Demonstrated ampicillin translocation through the bacterial pore, and described the effect of mutations within pore affecting molecule passage using ETP and MS | OmpF | |
| Provided a descriptive explanation about pathways of ions along channel surface using MS | OmpF | |
| Probed the interaction of peptides, magainin 2, and HPA3P with the pore, and displayed the effect of electric field on pore and peptide geometry using ETP | OmpF | |
| Demonstrated the translocation of ampicillin using multiscale approach combined with MS | OmpF | |
| Demonstrated the effective binding of carbenicillin, ertapenem, and ampicillin within the pore using X-ray crystallography and MS | OmpF | |
| Demonstrated the interaction involved in translocation of ampicillin, amoxicillin, carbenicillin, azlocillin, and piperacillin using ETP and MS | OmpF | |
| Demonstrated the effect of specific acid residue D113A substitution on susceptibility to cefepime, cefpirome, cefotaxime, ceftazidime, cefoxitin, and ampicillin using MIC and MS | OmpF | |
| Demonstrated the effective role of anti-loop 3 (Lys-16) residue in cefepime diffusion using LSA, ETP, and MS | OmpF | |
| Demonstrated the effect of ion concentration and charged residues at constriction zone on gating behavior of channel using ETP | OmpC | |
| Established the effect of three mutations within porins isolated from multidrug-resistant | OmpC | |
| Studied the interaction strengths of ceftriaxone, cefpirome, and ceftazidime using effective fluorescence quenching and ETP | OmpC, OmpF | |
| Demonstrated the influx of ceftriaxone, cefepime, ceftazidime, norfloxacin, ciprofloxacin, and enrofloxacin using a chip-based automated patch clamp technique based on ETP | OmpC, OmpF | |
| Demonstrated the effect of culture medium on porin expression and piperacillin–tazobactam susceptibility using MIC | OmpC, OmpF | |
| Using water as a probe, demonstrated macroscopic electric field inside water-filled channels using MS | OmpF, OmpC | |
| Demonstrated the permeation of imipenem and meropenem to be dependent on electric dipole alignment of the molecule with an internal electric field of Omps, and identified the “preorientation” region within Omps affecting antibiotic pathway using MS | OmpF, OmpC | |
| Demonstrated how the excess fixed positive charges within the Omps result in the characteristic anion selectivity using ETP | PhoE | |
| Demonstrated the effect of amino group (lysines) and carboxyl groups on pore ion selectivity using ETP | PhoE | |
| Demonstrated drug resistance by mutational loss of Omps, and measured the quantitative influx rates ofampicillin, benzylpenicillin, oxacillin, cloxacillin, cephalothin, cephaloridine, cefoxitin, cefamandole, cefotaxime, ceftazidime, ceftriaxone, cefepime, imipenem, ertapenem, novobiocin, and erythromycin using MIC | OmpK35, OmpK36 | |
| Examined the role of Omps in diffusion of ceftazidime–avibactam across the outer membrane using MIC | Omp35, Omp36 | |
| Studied imipenem resistance as a function of outer membrane permeability in different resistant clinical isolated strains using MIC | Omp36, Omp35 | |
| Demonstrated the role of porin in selective susceptibility toward ceftriaxone using LSA and ETP | Omp35 | |
| Demonstrated the effect of porin on the influx of ertapenem and cefepime using ETP and MIC | Omp36 | |
| Demonstrated resistance due to porin mutation, affecting permeability of imipenem, cefepime, and cefpirome, in clinical strains using MIC | Omp36 | |
| Demonstrated the effect of Omps on bacterial resistance to ceftazidime–avibactam, tigecycline, and colistin in clinical strains using MIC | OmpK36, OmpK35 | |
| Reported single-channel activity including broad-range conductance, gating dynamics, and cation selectivity for Omps subfamily using ETP | OccD1–OccD6 | |
| Explained the outer membrane uptake and characterized the carboxylate group interaction with central residues of the basic ladder (arginine and lysine) residues using ETP | OccD1–OccD6, | |
| Demonstrated channel activity conductance, gating transitions, one-open substate (K3), two-open substate | OccK1–OccK7 | |
| Elucidated conductance, gating properties, and the effect of internal constriction loop deletion on gating transitions using MS | OccK1 | |
| Demonstrated gating dynamics comprising enthalpy-driven and entropy-driven current transitions and the effect of loop deletion on activation enthalpies and entropies over channel transitions using ETP | OccK1 | |
| Demonstrated the effect of ion concentrations on gating transitions of the channel using ETP | OccK1 | |
| Provided a structural insight into substrate specificity and channel structure with monomeric 18-stranded β-barrel ensuing narrow constriction within pore using crystallography, X-ray, and ETP | OccD1 | |
| Studied the role of specific surface loop regions within pore determining imipenem passage using ETP | OccD1 | |
| Demonstrated the translocation of natural amino acid substrates to understand structure and dynamics of pore using MS | OccD1 | |
| Demonstrated the uptake of imipenem and meropenem using ETP | OccD3 | |
| Demonstrated the role of Omps in the uptake of tricarboxylate, isocitrate, and citrate using ETP | OccK5 | |
| Demonstrated diverse gating properties of the channel using ETP and MS | OccK5 | |
| Demonstrated the involvement of the Omps in temocillin transport into a bacterial cell using MIC | OccK1, OccK2 | |
| Demonstrated the ion selectivity of phosphate-specific pore, and established the energetics for transport of phosphate, sulfate, chloride, and potassium ion using MS | OprP | |
| Demonstrated the role of central-binding negatively charged residue (D94) in phosphate binding and selectivity using ETP and MS | OprP | |
| Investigated the role of central arginine (R133) in defining selectivity and ion transport properties of the pore using ETP and MS | OprP | |
| Demonstrated the effects of double mutations resulting in interchange of phosphate and diphosphate specificities of Omps using ETP and MS | OprP, OprO | |
| Demonstrated the structural features responsible for transport of amino acid residues via substrate-specific channel using LSA, ETP, and MS | OccK8 | |
| Demonstrated Omps uptake of glycine and ornithine and no uptake of glutamic acid, glucose, and imipenem using LSA and MS | CarO isoforms CarO1, CarO2, CarO3 | |
| Demonstrated channel conductance, cationic selectivity, and specificity toward meropenem, glutamic acid, arginine, and imipenem using ETP | CarO | |
| Demonstrated the function of the Omps in imipenem, meropenem, colistin, ceftazidime, and ciprofloxacin uptake using MIC | rOprD homologue | |
| Demonstrated Omps substrate specificities toward glycine, ornithine, arginine, putrescine, glutamic acid, glucose, maltose, benzoic acid, phenylalanine, tryptophan, imipenem, meropenem, ceftazidime, ampicillin, and fosfomycin using LSA and ETP | OccAB1–OccAB4 |
Abbreviations: Omps, outer membrane proteins; ETP, electrophysiology; MS, molecular simulation; LSA, liposome swelling assay; MIC, minimum inhibitory concentration; FRET, fluorescence resonance energy transfer.
Figure 3(A) Current recorded using staircase electrophysiology. A graphical representation depicting insertion of Omp over real time under applied potential. Recording time: 18 seconds. (B) Current histogram for the trace with each peak resembling a single Omp, showing, in total, approximately 45 Omps. (C) OmpF single channel–substrate interaction comparison: without substrate (blank), substrate 1 depicting no blockages, and substrate 2 inducing well-resolved channel blockage; a clear difference between the two substrates can be seen.
Abbreviation: Omp, outer membrane protein.
Figure 4(A) Intrinsic depiction of the two-dimensional free energy of translocation of β-lactamase inhibitor (avibactam), reassembled from metadynamic simulations. (B) Lateral view and (C) topmost view of the avibactam inside OmpF pore in the two lowest minima near the constriction region and at the subsequent transition state. Reprinted with permission from Ghai I, Pira A, Scorciapino MA, et al. General method to determine the flux of charged molecules through nanopores applied to beta-lactamase inhibitors and OmpF. J Phys Chem Lett. 2017;8(6):1295–1301.36 Copyright (2017) American Chemical Society.